Ratio Revelations: Syndax Pharmaceuticals Inc (SNDX)’s Financial Metrics in the Spotlight

For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.

Syndax Pharmaceuticals Inc (NASDAQ: SNDX) closed the day trading at $21.66 up 3.29% from the previous closing price of $20.97. In other words, the price has increased by $3.29 from its previous closing price. On the day, 0.97 million shares were traded. SNDX stock price reached its highest trading level at $21.69 during the session, while it also had its lowest trading level at $20.75.


For a better understanding of SNDX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.93 and its Current Ratio is at 8.93. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Scotiabank on January 31, 2024, Downgraded its rating to Sector Perform and sets its target price to $23 from $36 previously.

On December 22, 2023, Mizuho started tracking the stock assigning a Buy rating and target price of $45.

On October 25, 2023, BofA Securities started tracking the stock assigning a Buy rating and target price of $29.BofA Securities initiated its Buy rating on October 25, 2023, with a $29 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 09 ’23 when Morrison Briggs sold 52,855 shares for $18.27 per share. The transaction valued at 965,402 led to the insider holds 17,836 shares of the business.

Meury William sold 83,000 shares of SNDX for $1,697,810 on Aug 02 ’23. The Director now owns 48,000 shares after completing the transaction at $20.46 per share. On Jul 10 ’23, another insider, Morrison Briggs, who serves as the Director of the company, sold 52,855 shares for $20.40 each. As a result, the insider received 1,078,068 and left with 17,836 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SNDX now has a Market Capitalization of 1840820608 and an Enterprise Value of 1399046656.

Stock Price History:

Over the past 52 weeks, SNDX has reached a high of $25.34, while it has fallen to a 52-week low of $11.22. The 50-Day Moving Average of the stock is -3.07%, while the 200-Day Moving Average is calculated to be 13.40%.

Shares Statistics:

Over the past 3-months, SNDX traded about 1.06M shares per day on average, while over the past 10 days, SNDX traded about 983380 shares per day. A total of 84.83M shares are outstanding, with a floating share count of 80.59M. Insiders hold about 5.17% of the company’s shares, while institutions hold 102.67% stake in the company. Shares short for SNDX as of 1714435200 were 10109137 with a Short Ratio of 9.50, compared to 1711584000 on 9620763. Therefore, it implies a Short% of Shares Outstanding of 10109137 and a Short% of Float of 11.989999599999999.

Most Popular

[the_ad id="945"]